| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 21.05B | 13.48B | 20.14B | 31.81B | 31.64B |
| Gross Profit | 3.58B | 4.14B | 5.66B | 8.90B | 8.31B |
| EBITDA | 4.13B | 3.65B | 3.65B | 3.58B | 3.14B |
| Net Income | 2.21B | 1.99B | 1.92B | 1.58B | 1.58B |
Balance Sheet | |||||
| Total Assets | 290.32B | 277.10B | 270.83B | 261.63B | 284.73B |
| Cash, Cash Equivalents and Short-Term Investments | 9.14B | 39.09B | 40.31B | 44.78B | 37.80B |
| Total Debt | 100.43B | 94.08B | 11.51B | 13.41B | 16.75B |
| Total Liabilities | 276.33B | 265.39B | 260.39B | 252.69B | 272.62B |
| Stockholders Equity | 13.84B | 11.58B | 10.32B | 8.89B | 12.10B |
Cash Flow | |||||
| Free Cash Flow | 2.04B | 2.40B | 568.00M | -630.00M | 3.43B |
| Operating Cash Flow | 2.70B | 2.90B | 1.41B | 180.00M | 4.18B |
| Investing Cash Flow | -1.81B | -986.00M | -994.00M | -1.61B | -422.00M |
| Financing Cash Flow | -1.12B | -1.45B | -1.19B | -1.55B | -321.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | €935.67M | 7.53 | 12.15% | 7.43% | -29.74% | -57.59% | |
72 Outperform | €32.39B | 23.17 | 12.10% | 1.05% | 14.13% | 5.99% | |
62 Neutral | €231.37M | 2.78 | 16.88% | 3.86% | 4.31% | -15.86% | |
61 Neutral | €28.05B | 12.57 | 17.08% | 5.34% | -8.61% | 9.02% | |
57 Neutral | €6.63B | 17.54 | ― | 1.76% | -7.26% | 14.20% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
51 Neutral | €476.99M | 28.48 | ― | 5.24% | 11.25% | -76.44% |